Key Takeaways
- Normalized EBITDA has largely replaced simple collections formulas as the main driver of dental practice valuations in 2026, especially for practices generating $1 million or more in annual revenue.
- Individual buyers typically apply 4.5×–6.5× EBITDA multiples, while dental service organizations and private equity buyers often reach 7×–11×+ when the earnings base is carefully normalized and supported with documentation.
- Strong hygiene programs, diversified payer mix, and multiple providers can push EBITDA margins into the 22%–30% range, which tends to increase both valuation multiples and buyer interest.
- Normalization usually involves replacing owner compensation with market-rate dentist salaries, removing personal expenses, and documenting every adjustment so the number can withstand quality-of-earnings review.
- McLerran & Associates runs a competitive, auction-style process that has delivered approximately 30% higher valuations than owners who sell on their own, so schedule a free, confidential discovery call to explore what your practice may be worth.
How Normalized EBITDA Works in Dental Valuations
Normalized EBITDA, or Earnings Before Interest, Taxes, Depreciation, and Amortization, adjusted for owner-specific and non-recurring items, represents the sustainable, transferable operating cash flow a practice can generate under market-based assumptions. It gives buyers a practical estimate of how much the practice might earn if they owned it and paid a market-rate dentist to perform the clinical work.
The gap between what a practice reports on its tax return and its normalized EBITDA can be substantial. That gap can be where value is created or lost, depending on who prepares the numbers and how clearly the story is explained.
The table below illustrates how normalized EBITDA can translate into enterprise value across the two primary buyer types in 2026. Multiples are directional ranges drawn from current market data and can vary based on practice-specific factors discussed throughout this guide.
| Buyer Type | Typical EBITDA Multiple Range | Key Value Drivers | Deal Structure |
|---|---|---|---|
| Individual (private) buyer | 4.5×–6.5× | Bank financing capacity, single-dentist risk tolerance, local market comparables | Primarily cash at close, SBA-financed |
| Dental service organization / private equity buyer | 7×–11×+ | EBITDA scale, provider depth, payer mix, platform fit, geography | Cash, rollover equity, and earnout, with 60%–85% cash at close |
The same practice, with the same revenue, can produce a significantly higher valuation in the dental service organization market than in the private-buyer market, provided the normalized EBITDA is calculated carefully and defended through diligence. Once that earnings base is clear, the next question becomes which EBITDA margin levels tend to qualify practices for those stronger multiples.
EBITDA Margins That Attract Strong Dental Buyers
EBITDA margin, expressed as a percentage of net collections, is one of the primary profitability benchmarks buyers use to assess practice health. A well-run general practice typically achieves a normalized EBITDA margin in the 22%–26% range, with top-quartile performers reaching 28%–30% and bottom-quartile practices falling below 18%.
Several operational factors can move a practice’s margin, and therefore its multiple, within or outside these ranges. These factors generally fall into two categories: revenue quality and operational risk.
On the revenue quality side:
- Hygiene contribution. Buyers evaluate hygiene health using metrics such as hygiene production as a percentage of total production, hygienist productivity, reappointment rates, and active patient counts. A strong hygiene program signals recurring, owner-independent revenue, which can be one of the more durable earnings characteristics a practice can show.
- Payer mix. Fee-for-service practices with a high percentage of collections from non-insurance patients often support full or above-market multiples. Practices with high Medicaid production can experience multiple compression because the buyer universe narrows considerably.
On the operational risk side:
- Provider dependency. Practices where the selling doctor produces a high percentage of clinical revenue can experience valuation discounts, regardless of the multiple methodology. Buyers often price key-person risk through both a lower multiple and structural protections such as earnouts and escrow holdbacks.
- Specialty. Specialty practices, including oral surgery, orthodontics, endodontics, and periodontics, generally transact at higher EBITDA multiples than general dentistry. A specialty label alone does not create a premium, however, without transferable earnings quality and sufficient provider depth.
Dental Valuation Multiples by Practice Size
EBITDA scale in 2026 can be one of the more reliable indicators of which multiple range a practice may achieve. The table below presents directional ranges by revenue and EBITDA tier, segmented by buyer type. Every figure is drawn from current market data and should be treated as a range, not a guarantee, because your specific multiple can depend on the factors described throughout this guide.
| Practice Profile | Approximate EBITDA Range | Private Buyer Multiple | Dental service organization / Private equity Multiple |
|---|---|---|---|
| Solo GP, $800K–$1.2M revenue | Under $300K | 3.5×–5.0× | Limited institutional interest at this scale |
| Solo GP / small group, $1.2M–$2M revenue | $300K–$500K | 4.5×–5.5× | 5.5×–7.0× |
| Multi-doctor group, $2M–$4M revenue | $500K–$1M | 5.0×–6.5× | 7.0×–9.0× |
| Multi-location group / platform, $4M+ revenue | $1M+ | Less applicable | 9×–11×+ |
Headline EBITDA multiples have remained stable for two consecutive years in 2026, while the gap between the best and middle-tier offers on any given practice has widened significantly. That widening gap is a key reason a competitive, structured process, rather than a single-buyer negotiation, often determines whether a seller captures the top or the bottom of the applicable range.
SDE vs. EBITDA in Dental Practice Sales
Two earnings metrics appear frequently in dental practice transactions, and they serve different purposes. Knowing which one applies to your situation can be a foundation for any valuation discussion.
Seller’s Discretionary Earnings (SDE), which is the total economic benefit flowing to a single owner-operator including salary, benefits, and personal expenses run through the practice, is often the appropriate metric for smaller, owner-operated practices sold to individual dentist-buyers. In an SDE calculation, the owner’s full compensation is added back to earnings, which produces a larger base number that reflects what a working owner-buyer might take home.
Normalized EBITDA is the metric dental service organizations and private equity buyers usually require. Instead of adding back the owner’s full compensation, normalized EBITDA replaces it with a market-rate replacement-dentist salary. This approach produces a lower earnings base than SDE, but it is the number institutional buyers typically use to apply their multiples, and those multiples can be substantially higher.
The practical implication can be significant. A practice that looks attractive under SDE may look even more attractive under normalized EBITDA when the right buyer applies a dental service organization-level multiple. A practice with a high owner draw and thin margins may see its normalized EBITDA compress when compensation is reset to market. Knowing which number applies, and why, before going to market can support a defensible valuation. For practices targeting dental service organization buyers, that understanding leads directly into building a normalized EBITDA calculation that can withstand scrutiny.
Normalizing EBITDA for a DSO-Focused Sale
Normalization converts a practice’s reported financials into a picture of sustainable, transferable earnings under market-based assumptions. A CPA-led normalization process completed before the practice goes to market can separate a valuation that holds up through diligence from one that gets renegotiated at the closing table.
The following checklist covers several common normalization adjustments in dental practice transactions. Not every adjustment increases EBITDA, and some can reduce it, so a credible normalization schedule usually acknowledges both directions.
Owner Compensation Normalization
- Replace actual owner draw with market-rate replacement-dentist cost. If an owner pays themselves $600,000 while an equivalent associate would cost $280,000, the $320,000 difference is added to normalized EBITDA.
- Normalize family payroll for relatives paid by the practice who would not continue under new ownership.
Personal and Discretionary Expenses
- Personal vehicle costs, typically 80%–100% personal use
- Owner life insurance premiums
- Private club memberships
- Personal travel labeled as continuing education
- Meals and entertainment above operational norms
- Owner retirement contributions above the staff-plan match
- Other discretionary add-backs such as automobile expense, continuing education, memberships, auto insurance, and health insurance above staff benefit levels
One-Time and Non-Recurring Costs
- Legal fees and lawsuit settlements
- One-time consulting or strategy engagements
- Major equipment purchases expensed rather than capitalized
- Pre-sale preparation costs and valuation fees
- Non-recurring repairs such as HVAC, plumbing, or buildout work
Related-Party and Non-Market Items
- Above- or below-market rent when the owner also owns the building. Market rent for dental practices typically runs 5%–8% of collections, and the adjustment is the difference between actual rent and that benchmark.
- Non-operating income or expenses unrelated to practice operations
Downward Adjustments That Reduce Normalized EBITDA
- Under-market associate compensation that would likely need to be corrected post-close
- Deferred maintenance or equipment catch-up costs
- Under-investment in marketing relative to the 2%–3% of revenue sustainable benchmark, which buyers may treat as a future operating expense
Every add-back must be traceable to the actual books and supported by three years of consistent, comparable monthly financial statements, or a buyer’s due diligence team may reject it. McLerran & Associates builds this documentation before the practice goes to market, so the numbers are more likely to hold when buyers review them in detail.
Choosing Between Private Buyer and DSO Paths
The decision a practice owner makes about which path to pursue can be more consequential than which specific buyer to choose. For owners in the $1.5M–$3M revenue range, both paths may be realistic, and the better choice often depends on after-tax cash across practical time horizons rather than headline multiples alone.
The table below illustrates a directional, side-by-side comparison for a hypothetical premier practice with $2M in collections and $500,000 in normalized EBITDA. These figures are illustrative, and actual outcomes can depend on deal structure, tax treatment, equity performance, and individual circumstances. Dentists should consult their tax and legal advisors before making any decisions.
| Horizon | Private Buyer Path (est. after-tax) | Dental service organization Path — Cash + Equity (est. after-tax) |
|---|---|---|
| At close | Higher cash percentage, lower total enterprise value at ~5×–6× EBITDA | 60%–85% cash at close at ~7×–9× EBITDA, with the remainder in equity and earnout |
| 3 years | Distributions from continued ownership or clean exit proceeds | Cash at close plus earnout payments, with equity value building |
| 5–7 years | N/A (seller has exited) | Potential recapitalization event, and 78% of dental service organization buyers anticipate recapitalization within 12–36 months, which can create a second liquidity event for equity holders |
| 10 years | N/A | Full equity realization at recapitalization, where cumulative after-tax proceeds can exceed the private-buyer path for well-chosen dental service organization partners |
Tax treatment can be a major factor. Much of a dental service organization deal is often structured as a sale of goodwill, which may qualify for long-term capital gains treatment rather than ordinary income rates, creating a meaningful difference in after-tax proceeds. The private-buyer path can also carry favorable tax treatment depending on structure. Neither path is universally superior, so the right answer usually depends on your specific numbers, timeline, and goals.
Using Competition to Improve Your Deal
A seller who negotiates with one buyer has limited leverage. A seller who negotiates with ten vetted, competing buyers can often shift the market in their favor. Practices taken through a structured, competitive process have received final transaction values averaging 50% above initial unsolicited offers.
McLerran & Associates runs a structured, auction-like bid process, typically 45–60 days, that often generates around 10 offers per listing from a vetted pool of well-qualified buyers. Dental service organizations known for poor post-close environments are removed from consideration before the process begins, so sellers see the real market without exposure to buyers who may not serve their interests. The process narrows from initial offers to in-person meetings with the top one to three finalists, with McLerran managing the competition and forecasting each finalist’s deal in real time.
The result can be not only a higher number but also stronger terms, because competitive tension gives the seller the standing to push back on earnout structure, equity type, and post-close obligations that a single-buyer negotiation might never surface.
Evaluating Buyer Fit, Not Just Price
The highest offer does not always represent the best long-term fit. Up to 40% of a dental service organization deal can be paid in equity rather than cash, which means the seller effectively becomes an investor in the acquiring organization. Evaluating that investment can be just as important as negotiating the headline number.
McLerran & Associates helps clients evaluate each finalist buyer across three main dimensions.
- Financial health. The team reviews whether the dental service organization is profitable at the location level, whether revenue is still growing at practices it already owns, and whether its private equity sponsor is well-capitalized and experienced in dental.
- Deal structure. Key elements include cash at close, joint-venture equity that pays distributions but may have a lower ceiling, holding-company equity that pays no distributions but can have a higher ceiling at recapitalization, and earnout terms, including whether the earnout is pro-rata, where a near-miss still pays most of the earnout, or binary, where a near-miss pays nothing.
- Cultural and operational fit. Considerations include clinical autonomy, staff retention commitments, patient care philosophy, and the support infrastructure the dental service organization actually delivers, not just what appears in a pitch deck.
For private-buyer transactions, fit often means finding a qualified individual dentist who will preserve the practice’s goodwill, care for its patients, and honor the legacy the selling doctor built, rather than simply the buyer who can close fastest.
Maximizing Value Through Diligence-Ready Numbers
A signed letter of intent does not guarantee a closed deal. The period between LOI and closing, when the buyer’s quality-of-earnings (QoE) team reviews every line of the normalization schedule, is often where deals get renegotiated or fall apart. Quality-of-earnings defense focuses on protecting the agreed valuation through that review.
McLerran & Associates builds its normalization analysis to withstand a QoE review before the practice goes to market. When a buyer’s team challenges an add-back, McLerran responds with documentation. When a buyer attempts to reduce the price, McLerran can remind them, in a professional way, that other vetted bidders are waiting. That posture is more credible when the competitive process was real and the valuation work was diligence-grade from the start.
The numbers behind McLerran’s approach include approximately 2,000 successful practice sales, roughly $2 billion in closed transaction volume, more than 10,000 practices evaluated, and a transaction rate of approximately 85%–90%, compared to an industry norm closer to 35%–40%. Clients who engage McLerran typically achieve the valuation premium described earlier, roughly 30% above going it alone.
Schedule a free, confidential discovery call with McLerran & Associates to explore how a CPA-led EBITDA analysis and a structured competitive process can help protect and maximize the value you have spent a career building.
Frequently Asked Questions
What is a good EBITDA for a dental practice?
A well-run general dental practice typically achieves a normalized EBITDA margin of 22%–26% of net collections, with top-performing practices reaching 28%–30%. Specialty practices, including oral surgery and orthodontics, often achieve higher margins. In absolute dollar terms, the EBITDA level can matter as much as the margin. Practices below roughly $300,000 in normalized EBITDA tend to attract primarily individual dentist-buyers, while those above $500,000 begin to attract more meaningful dental service organization and private equity interest. Practices with strong hygiene programs, diversified payer mix, and multiple providers often sit at the higher end of the margin range and can command stronger multiples as a result.
How do I normalize EBITDA for a dental service organization sale?
Normalizing EBITDA for a dental service organization sale typically involves several steps. First, replace your actual owner compensation with a market-rate replacement-dentist salary. Next, remove personal and discretionary expenses run through the practice. Then add back one-time or non-recurring costs and adjust for any related-party items such as above-market rent on a building you own. Normalization is not one-directional, so if your associate compensation is below market or you have deferred equipment maintenance, those items can reduce your normalized EBITDA. Every adjustment should be documented and traceable to your financial statements, because a dental service organization’s quality-of-earnings team will usually review each one. A CPA-led normalization process completed before going to market can be one of the more reliable ways to help your number hold through diligence.
What is the difference between SDE and EBITDA in dental practice valuation?
Seller’s Discretionary Earnings, or SDE, adds back the owner’s full compensation to earnings and is typically used for smaller, owner-operated practices sold to individual dentist-buyers. Normalized EBITDA replaces the owner’s actual compensation with a market-rate replacement-dentist salary, which produces a lower number, but it is the metric dental service organization and private equity buyers usually apply their higher multiples to. For a practice generating $2 million in collections where the owner draws $500,000 but a replacement dentist would cost $280,000, the SDE calculation adds back the full $500,000, while the EBITDA calculation adds back only the $220,000 difference. The right metric can depend on which buyer market you are targeting, and for many premier practices, modeling both can be the clearest way to see which path may produce the better after-tax outcome.
Are dental practice EBITDA multiples still strong in 2026?
Headline multiples have remained broadly stable for two consecutive years, although the range between the best and middle-tier offers on any given practice has widened. Premium practices, those with strong EBITDA margins, multiple providers, diversified payer mix, and robust hygiene programs, continue to attract competitive offers in the upper portions of applicable ranges. Practices with provider dependency, Medicaid concentration, or thin margins often face more conservative buyer underwriting. The most important factor in capturing a strong multiple in 2026 is often preparation rather than market timing. A defensible normalized EBITDA, a structured competitive process, and quality-of-earnings defense through diligence can be some of the main factors that influence outcomes.
Conclusion: Protect and Maximize the Value You Built
A premier dental practice can be one of the most valuable assets a dentist will ever own. The difference between realizing that value and leaving it on the table often comes down to three elements: a normalized EBITDA that is calculated carefully and defended through diligence, a competitive process that creates genuine tension among well-qualified buyers, and a sell-side advisor whose only client is you.
McLerran & Associates has guided practice owners through the volume of transactions described earlier, with the high transaction rate noted earlier (approximately 85%–90%) and a documented valuation premium of approximately 30% over going it alone. The firm’s CPA-led EBITDA analysis is built to hold up when buyers review the details, and its structured auction process is designed to help ensure that the market, rather than a single buyer, sets the price.
Schedule a free, confidential discovery call with McLerran & Associates to discuss your practice, your goals, and what a diligence-grade valuation may reveal about your options in both markets.
Owners who are not ready to sell yet can still begin preparing. Consider joining the McLerran M&A Summit, October 29–30, 2026, a dental-only event designed for owners who have not decided on their path. Attendees can hear presentations, meet expert panels, participate in one-on-one CPA sessions, earn 4 CE credits, and receive a complimentary practice valuation (a $2,500 value). The summit can be a high-trust, low-pressure way to get educated before making one of the most consequential financial decisions of your career.
